查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1595082

有機藥用輔料市場：按功能、形狀和產品分類 - 全球預測 2025-2030

Organic Pharmaceutical Excipients Market by Function (Binders, Coating Agents, Colorants), Form (Oral Formulations, Parenteral Formulations, Topical Formulations), Product - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 192 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年有機藥用輔料市場價值為114.1億美元，預計到2024年將達到125.2億美元，複合年成長率為9.81%，到2030年將達到219.9億美元。

有機藥用輔料市場因其在藥物配方和藥物輸送系統中的重要作用而受到關注。這些賦形劑主要是天然衍生的非活性成分，用於促進藥物製造過程並提高患者的可接受性。他們的需求源於其提高藥物生物有效性、穩定性和控制釋放的能力，這使得它們在藥品製造中至關重要。它應用於錠劑、膠囊、注射劑等多種劑型，其最終用途主要在製藥領域，如學名藥製造和創新藥物開發。關鍵的成長要素包括快速成長的製藥業、藥物傳遞技術的進步以及對天然和無毒賦形劑選擇的日益偏好。成長機會也存在於賦形劑個人化領域，以定製藥物輸送和最佳化功能，以及學名藥生產不斷成長的新興市場。公司應專注於投資永續採購和創新，以滿足嚴格的監管標準，同時保持成本效益。然而，監管障礙、批次不一致和研發成本上升等挑戰可能會阻礙市場進步。透過強力的合規策略和對先進製造技術的投資來解決這些限制至關重要。此外，創新領域包括開發多功能賦形劑，以提高溶解度和穩定性並減少生態足跡。製藥公司和研究機構之間的合作可以促進新輔料的開發。作為一個競爭激烈且不斷成長的市場，隨著消費者和監管要求的發展，市場擴張潛力巨大。透過研究主導的策略和適應性產品提供領先的公司將獲得顯著的收益。因此，透過加強策略聯盟並專注於永續創新，我們可以釋放有機藥用輔料領域的巨大市場潛力。

主要市場統計
基準年[2023] 114.1億美元
預測年份 [2024] 125.2億美元
預測年份 [2030] 219.9億美元
複合年成長率（%） 9.81%

市場動態：快速發展的有機藥用輔料市場的關鍵市場洞察

供需的動態交互作用正在改變有機藥用輔料市場。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 有機醫藥原料需求增加背景下醫藥產業的成長
    • 學名藥、生物相似藥和生物製藥的需求快速成長
    • 有機醫藥原料有吸引力的投資
  • 市場限制因素
    • 法規結構的變化
    • 原物料價格波動
  • 市場機會
    • 多功能賦形劑的潛力不斷增加
    • 改善有機藥品生產
  • 市場挑戰
    • 安全和品質問題

波特五力戰略工具駕馭有機藥用輔料市場

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解有機藥用輔料市場的外部影響

外部宏觀環境因素在塑造有機藥用輔料市場的表現動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解有機藥用輔料市場的競爭狀況

對有機藥用輔料市場的詳細市場佔有率分析可以對供應商的業績進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣有機藥用輔料市場供應商的績效評估

FPNV定位矩陣是評估有機藥用輔料市場供應商的重要工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議描繪了有機藥用輔料市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，對有機藥用輔料市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 對有機醫藥原料的需求不斷成長支持醫藥產業的成長
      • 學名藥、生物相似藥和生物製藥的需求快速成長
      • 有機醫藥原料有吸引力的投資
    • 抑制因素
      • 法規結構的變化
      • 原物料價格波動
    • 機會
      • 擴大多功能賦形劑的潛力
      • 改善有機藥品生產
    • 任務
      • 安全和品質問題
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章有機藥用輔料市場：依功能

  • 活頁夾
  • 被覆劑
  • 著色劑
  • 崩壞
  • 乳化劑
  • 填充劑和稀釋劑
  • 調味劑/甜味劑
  • 潤滑劑和潤滑劑
  • 防腐劑
  • 懸浮劑和黏稠劑

第7章有機藥用輔料市場：依形式

  • 口服製劑
    • 膠囊
      • 硬明膠膠囊
      • 軟明膠膠囊
    • 液體配方
    • 藥片
  • 腸外製劑
  • 局部製劑

第8章有機藥用輔料市場：依產品

  • 碳水化合物
    • 纖維素
      • 纖維素酯
      • 纖維素醚
      • CMC和交聯羧甲基纖維素鈉
      • 結晶纖維素
    • 澱粉
      • 修飾澱粉
      • 乾澱粉
      • 改質澱粉
    • 醣類
      • 實際含糖量
      • 人工甜味劑
      • 糖醇
  • 油脂化學品
    • 脂醇類
    • 甘油
    • 礦物硬脂酸鹽
      • 礦物油
      • 礦物蠟
      • 凡士林
  • 石化產品
    • 丙烯酸聚合物
    • 乙二醇
      • 聚乙二醇
      • 丙二醇
    • 礦物碳氫化合物
    • 聚維酮
  • 蛋白質

第9章美洲有機藥用輔料市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太有機藥用輔料市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章歐洲、中東和非洲有機藥用輔料市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • ADM Germany GmbH
  • BASF SE
  • Cargill Inc.
  • Croda International Plc
  • DuPont de Nemours, Inc.
  • Evonik Industries AG
  • FMC Corporation
  • Innophos Holdings, Inc.
  • Kerry Group plc
  • Merck KGaA
  • Roquette Freres SA
  • SILVERLINE CHEMICALS LTD.
  • The Lubrizol Corporation
  • The Procter & Gamble Company
  • Wacker Chemie AG
Product Code: MRR-433BAD49EDB9

The Organic Pharmaceutical Excipients Market was valued at USD 11.41 billion in 2023, expected to reach USD 12.52 billion in 2024, and is projected to grow at a CAGR of 9.81%, to USD 21.99 billion by 2030.

The market for organic pharmaceutical excipients is gaining traction due to their critical role in drug formulation and delivery systems. These excipients are non-active constituents, mainly derived from natural sources, used to facilitate the drug manufacturing process and enhance patient acceptability. Their necessity stems from their ability to improve the drug's bioavailability, stability, and controlled release, making them indispensable in pharmaceutical production. They are applied across various formulations, including tablets, capsules, and injectables, with end-use primarily in pharma sectors like generic drug manufacturing and innovative drug development. Key growth factors include the burgeoning pharmaceutical industry, advancements in drug delivery technology, and a rising preference for natural and non-toxic excipient options. Opportunities for growth exist in personalizing excipients to tailor drug delivery and optimize functionality, as well as in emerging markets where generic drug production is on the rise. Companies should focus on sustainable sourcing and investing in innovation to meet stringent regulatory standards while maintaining cost efficiency. However, challenges such as regulatory hurdles, batch inconsistencies, and high R&D costs could impede market progression. Addressing these limitations through robust compliance strategies and investing in advanced manufacturing technologies is crucial. Furthermore, areas for innovation include developing multifunctional excipients that offer enhanced solubility and stability, alongside a reduced ecological footprint. Collaborations between pharmaceutical companies and research institutes can foster novel excipient development. Given its competitive and growing nature, the market offers vast potential for expansion as consumer and regulatory demands evolve. Companies that stay ahead with research-driven strategies and adaptable product offerings stand poised to benefit significantly. Therefore, enhancing strategic alliances and focusing on sustainable innovation can unlock immense market potential in the realm of organic pharmaceutical excipients.

KEY MARKET STATISTICS
Base Year [2023] USD 11.41 billion
Estimated Year [2024] USD 12.52 billion
Forecast Year [2030] USD 21.99 billion
CAGR (%) 9.81%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Organic Pharmaceutical Excipients Market

The Organic Pharmaceutical Excipients Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing pharmaceutical industry backed by the rising demand for organic pharmaceutical ingredients
    • Surge in demand for generic drugs, biosimilars, and biopharmaceuticals
    • Attractive investments in the organic pharmaceutical ingredients
  • Market Restraints
    • Changing regulatory framework
    • Fluctuating prices of raw materials
  • Market Opportunities
    • Growing potential of multifunctional excipients
    • improvements in organic pharmaceutical manufacturing
  • Market Challenges
    • Safety and quality concerns

Porter's Five Forces: A Strategic Tool for Navigating the Organic Pharmaceutical Excipients Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Organic Pharmaceutical Excipients Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Organic Pharmaceutical Excipients Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Organic Pharmaceutical Excipients Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Organic Pharmaceutical Excipients Market

A detailed market share analysis in the Organic Pharmaceutical Excipients Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Organic Pharmaceutical Excipients Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Organic Pharmaceutical Excipients Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Organic Pharmaceutical Excipients Market

A strategic analysis of the Organic Pharmaceutical Excipients Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Organic Pharmaceutical Excipients Market, highlighting leading vendors and their innovative profiles. These include ADM Germany GmbH, BASF SE, Cargill Inc., Croda International Plc, DuPont de Nemours, Inc., Evonik Industries AG, FMC Corporation, Innophos Holdings, Inc., Kerry Group plc, Merck KGaA, Roquette Freres S.A., SILVERLINE CHEMICALS LTD., The Lubrizol Corporation, The Procter & Gamble Company, and Wacker Chemie AG.

Market Segmentation & Coverage

This research report categorizes the Organic Pharmaceutical Excipients Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Function, market is studied across Binders, Coating Agents, Colorants, Disintegrants, Emulsifying Agents, Fillers & Diluents, Flavoring Agents & Sweeteners, Lubricants & Glidants, Preservatives, and Suspending & Viscosity Agents.
  • Based on Form, market is studied across Oral Formulations, Parenteral Formulations, and Topical Formulations. The Oral Formulations is further studied across Capsules, Liquid Formulation, and Tablets. The Capsules is further studied across Hard Gelatin Capsules and Soft Gelatin Capsules.
  • Based on Product, market is studied across Carbohydrates, Oleochemicals, Petrochemicals, and Proteins. The Carbohydrates is further studied across Cellulose, Starch, and Sugars. The Cellulose is further studied across Cellulose Esters, Cellulose Ethers, CMC & Croscarmellose Sodium, and Microcrystalline Cellulose. The Starch is further studied across Converted Starch, Dried Starch, and Modified Starch. The Sugars is further studied across Actual Sugars, Artificial Sweeteners, and Sugar Alcohols. The Oleochemicals is further studied across Fatty Alcohols, Glycerin, and Mineral Stearates. The Mineral Stearates is further studied across Mineral Oils, Mineral Waxes, and Petrolatum. The Petrochemicals is further studied across Acrylic Polymers, Glycols, Mineral Hydrocarbons, and Povidones. The Glycols is further studied across Polyethylene Glycol and Propylene Glycol.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing pharmaceutical industry backed by the rising demand for organic pharmaceutical ingredients
      • 5.1.1.2. Surge in demand for generic drugs, biosimilars, and biopharmaceuticals
      • 5.1.1.3. Attractive investments in the organic pharmaceutical ingredients
    • 5.1.2. Restraints
      • 5.1.2.1. Changing regulatory framework
      • 5.1.2.2. Fluctuating prices of raw materials
    • 5.1.3. Opportunities
      • 5.1.3.1. Growing potential of multifunctional excipients
      • 5.1.3.2. improvements in organic pharmaceutical manufacturing
    • 5.1.4. Challenges
      • 5.1.4.1. Safety and quality concerns
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Organic Pharmaceutical Excipients Market, by Function

  • 6.1. Introduction
  • 6.2. Binders
  • 6.3. Coating Agents
  • 6.4. Colorants
  • 6.5. Disintegrants
  • 6.6. Emulsifying Agents
  • 6.7. Fillers & Diluents
  • 6.8. Flavoring Agents & Sweeteners
  • 6.9. Lubricants & Glidants
  • 6.10. Preservatives
  • 6.11. Suspending & Viscosity Agents

7. Organic Pharmaceutical Excipients Market, by Form

  • 7.1. Introduction
  • 7.2. Oral Formulations
    • 7.2.1. Capsules
      • 7.2.1.1. Hard Gelatin Capsules
      • 7.2.1.2. Soft Gelatin Capsules
    • 7.2.2. Liquid Formulation
    • 7.2.3. Tablets
  • 7.3. Parenteral Formulations
  • 7.4. Topical Formulations

8. Organic Pharmaceutical Excipients Market, by Product

  • 8.1. Introduction
  • 8.2. Carbohydrates
    • 8.2.1. Cellulose
      • 8.2.1.1. Cellulose Esters
      • 8.2.1.2. Cellulose Ethers
      • 8.2.1.3. CMC & Croscarmellose Sodium
      • 8.2.1.4. Microcrystalline Cellulose
    • 8.2.2. Starch
      • 8.2.2.1. Converted Starch
      • 8.2.2.2. Dried Starch
      • 8.2.2.3. Modified Starch
    • 8.2.3. Sugars
      • 8.2.3.1. Actual Sugars
      • 8.2.3.2. Artificial Sweeteners
      • 8.2.3.3. Sugar Alcohols
  • 8.3. Oleochemicals
    • 8.3.1. Fatty Alcohols
    • 8.3.2. Glycerin
    • 8.3.3. Mineral Stearates
      • 8.3.3.1. Mineral Oils
      • 8.3.3.2. Mineral Waxes
      • 8.3.3.3. Petrolatum
  • 8.4. Petrochemicals
    • 8.4.1. Acrylic Polymers
    • 8.4.2. Glycols
      • 8.4.2.1. Polyethylene Glycol
      • 8.4.2.2. Propylene Glycol
    • 8.4.3. Mineral Hydrocarbons
    • 8.4.4. Povidones
  • 8.5. Proteins

9. Americas Organic Pharmaceutical Excipients Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Organic Pharmaceutical Excipients Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Organic Pharmaceutical Excipients Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. ADM Germany GmbH
  • 2. BASF SE
  • 3. Cargill Inc.
  • 4. Croda International Plc
  • 5. DuPont de Nemours, Inc.
  • 6. Evonik Industries AG
  • 7. FMC Corporation
  • 8. Innophos Holdings, Inc.
  • 9. Kerry Group plc
  • 10. Merck KGaA
  • 11. Roquette Freres S.A.
  • 12. SILVERLINE CHEMICALS LTD.
  • 13. The Lubrizol Corporation
  • 14. The Procter & Gamble Company
  • 15. Wacker Chemie AG

LIST OF FIGURES

  • FIGURE 1. ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET RESEARCH PROCESS
  • FIGURE 2. ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FORM, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FORM, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET DYNAMICS
  • TABLE 7. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY BINDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COATING AGENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COLORANTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY DISINTEGRANTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY EMULSIFYING AGENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FILLERS & DILUENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FLAVORING AGENTS & SWEETENERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY LUBRICANTS & GLIDANTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRESERVATIVES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SUSPENDING & VISCOSITY AGENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ORAL FORMULATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CAPSULES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY HARD GELATIN CAPSULES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOFT GELATIN CAPSULES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CAPSULES, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY LIQUID FORMULATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY TABLETS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PARENTERAL FORMULATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY TOPICAL FORMULATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CELLULOSE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CELLULOSE ESTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CELLULOSE ETHERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CMC & CROSCARMELLOSE SODIUM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY MICROCRYSTALLINE CELLULOSE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CELLULOSE, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY STARCH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 38. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CONVERTED STARCH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 39. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY DRIED STARCH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 40. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY MODIFIED STARCH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 41. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY STARCH, 2018-2030 (USD MILLION)
  • TABLE 42. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SUGARS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 43. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ACTUAL SUGARS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 44. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ARTIFICIAL SWEETENERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 45. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SUGAR ALCOHOLS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 46. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SUGARS, 2018-2030 (USD MILLION)
  • TABLE 47. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 48. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY OLEOCHEMICALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 49. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FATTY ALCOHOLS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 50. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY GLYCERIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 51. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY MINERAL STEARATES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 52. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY MINERAL OILS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 53. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY MINERAL WAXES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 54. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PETROLATUM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 55. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY MINERAL STEARATES, 2018-2030 (USD MILLION)
  • TABLE 56. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY OLEOCHEMICALS, 2018-2030 (USD MILLION)
  • TABLE 57. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PETROCHEMICALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 58. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ACRYLIC POLYMERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 59. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY GLYCOLS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 60. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYETHYLENE GLYCOL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 61. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PROPYLENE GLYCOL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 62. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY GLYCOLS, 2018-2030 (USD MILLION)
  • TABLE 63. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY MINERAL HYDROCARBONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 64. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POVIDONES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 65. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PETROCHEMICALS, 2018-2030 (USD MILLION)
  • TABLE 66. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PROTEINS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 67. AMERICAS ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 68. AMERICAS ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 69. AMERICAS ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 70. AMERICAS ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CAPSULES, 2018-2030 (USD MILLION)
  • TABLE 71. AMERICAS ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 72. AMERICAS ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 73. AMERICAS ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CELLULOSE, 2018-2030 (USD MILLION)
  • TABLE 74. AMERICAS ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY STARCH, 2018-2030 (USD MILLION)
  • TABLE 75. AMERICAS ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SUGARS, 2018-2030 (USD MILLION)
  • TABLE 76. AMERICAS ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY OLEOCHEMICALS, 2018-2030 (USD MILLION)
  • TABLE 77. AMERICAS ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY MINERAL STEARATES, 2018-2030 (USD MILLION)
  • TABLE 78. AMERICAS ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PETROCHEMICALS, 2018-2030 (USD MILLION)
  • TABLE 79. AMERICAS ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY GLYCOLS, 2018-2030 (USD MILLION)
  • TABLE 80. AMERICAS ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 81. ARGENTINA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 82. ARGENTINA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 83. ARGENTINA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 84. ARGENTINA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CAPSULES, 2018-2030 (USD MILLION)
  • TABLE 85. ARGENTINA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 86. ARGENTINA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 87. ARGENTINA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CELLULOSE, 2018-2030 (USD MILLION)
  • TABLE 88. ARGENTINA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY STARCH, 2018-2030 (USD MILLION)
  • TABLE 89. ARGENTINA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SUGARS, 2018-2030 (USD MILLION)
  • TABLE 90. ARGENTINA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY OLEOCHEMICALS, 2018-2030 (USD MILLION)
  • TABLE 91. ARGENTINA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY MINERAL STEARATES, 2018-2030 (USD MILLION)
  • TABLE 92. ARGENTINA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PETROCHEMICALS, 2018-2030 (USD MILLION)
  • TABLE 93. ARGENTINA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY GLYCOLS, 2018-2030 (USD MILLION)
  • TABLE 94. BRAZIL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 95. BRAZIL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 96. BRAZIL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 97. BRAZIL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CAPSULES, 2018-2030 (USD MILLION)
  • TABLE 98. BRAZIL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 99. BRAZIL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 100. BRAZIL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CELLULOSE, 2018-2030 (USD MILLION)
  • TABLE 101. BRAZIL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY STARCH, 2018-2030 (USD MILLION)
  • TABLE 102. BRAZIL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SUGARS, 2018-2030 (USD MILLION)
  • TABLE 103. BRAZIL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY OLEOCHEMICALS, 2018-2030 (USD MILLION)
  • TABLE 104. BRAZIL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY MINERAL STEARATES, 2018-2030 (USD MILLION)
  • TABLE 105. BRAZIL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PETROCHEMICALS, 2018-2030 (USD MILLION)
  • TABLE 106. BRAZIL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY GLYCOLS, 2018-2030 (USD MILLION)
  • TABLE 107. CANADA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 108. CANADA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 109. CANADA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 110. CANADA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CAPSULES, 2018-2030 (USD MILLION)
  • TABLE 111. CANADA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 112. CANADA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 113. CANADA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CELLULOSE, 2018-2030 (USD MILLION)
  • TABLE 114. CANADA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY STARCH, 2018-2030 (USD MILLION)
  • TABLE 115. CANADA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SUGARS, 2018-2030 (USD MILLION)
  • TABLE 116. CANADA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY OLEOCHEMICALS, 2018-2030 (USD MILLION)
  • TABLE 117. CANADA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY MINERAL STEARATES, 2018-2030 (USD MILLION)
  • TABLE 118. CANADA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PETROCHEMICALS, 2018-2030 (USD MILLION)
  • TABLE 119. CANADA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY GLYCOLS, 2018-2030 (USD MILLION)
  • TABLE 120. MEXICO ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 121. MEXICO ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 122. MEXICO ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 123. MEXICO ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CAPSULES, 2018-2030 (USD MILLION)
  • TABLE 124. MEXICO ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 125. MEXICO ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 126. MEXICO ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CELLULOSE, 2018-2030 (USD MILLION)
  • TABLE 127. MEXICO ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY STARCH, 2018-2030 (USD MILLION)
  • TABLE 128. MEXICO ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SUGARS, 2018-2030 (USD MILLION)
  • TABLE 129. MEXICO ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY OLEOCHEMICALS, 2018-2030 (USD MILLION)
  • TABLE 130. MEXICO ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY MINERAL STEARATES, 2018-2030 (USD MILLION)
  • TABLE 131. MEXICO ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PETROCHEMICALS, 2018-2030 (USD MILLION)
  • TABLE 132. MEXICO ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY GLYCOLS, 2018-2030 (USD MILLION)
  • TABLE 133. UNITED STATES ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 134. UNITED STATES ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 135. UNITED STATES ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 136. UNITED STATES ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CAPSULES, 2018-2030 (USD MILLION)
  • TABLE 137. UNITED STATES ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 138. UNITED STATES ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 139. UNITED STATES ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CELLULOSE, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED STATES ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY STARCH, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED STATES ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SUGARS, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED STATES ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY OLEOCHEMICALS, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED STATES ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY MINERAL STEARATES, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED STATES ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PETROCHEMICALS, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED STATES ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY GLYCOLS, 2018-2030 (USD MILLION)
  • TABLE 146. UNITED STATES ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 147. ASIA-PACIFIC ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 148. ASIA-PACIFIC ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 149. ASIA-PACIFIC ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 150. ASIA-PACIFIC ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CAPSULES, 2018-2030 (USD MILLION)
  • TABLE 151. ASIA-PACIFIC ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 152. ASIA-PACIFIC ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 153. ASIA-PACIFIC ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CELLULOSE, 2018-2030 (USD MILLION)
  • TABLE 154. ASIA-PACIFIC ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY STARCH, 2018-2030 (USD MILLION)
  • TABLE 155. ASIA-PACIFIC ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SUGARS, 2018-2030 (USD MILLION)
  • TABLE 156. ASIA-PACIFIC ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY OLEOCHEMICALS, 2018-2030 (USD MILLION)
  • TABLE 157. ASIA-PACIFIC ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY MINERAL STEARATES, 2018-2030 (USD MILLION)
  • TABLE 158. ASIA-PACIFIC ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PETROCHEMICALS, 2018-2030 (USD MILLION)
  • TABLE 159. ASIA-PACIFIC ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY GLYCOLS, 2018-2030 (USD MILLION)
  • TABLE 160. ASIA-PACIFIC ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 161. AUSTRALIA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 162. AUSTRALIA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 163. AUSTRALIA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 164. AUSTRALIA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CAPSULES, 2018-2030 (USD MILLION)
  • TABLE 165. AUSTRALIA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 166. AUSTRALIA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 167. AUSTRALIA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CELLULOSE, 2018-2030 (USD MILLION)
  • TABLE 168. AUSTRALIA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY STARCH, 2018-2030 (USD MILLION)
  • TABLE 169. AUSTRALIA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SUGARS, 2018-2030 (USD MILLION)
  • TABLE 170. AUSTRALIA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY OLEOCHEMICALS, 2018-2030 (USD MILLION)
  • TABLE 171. AUSTRALIA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY MINERAL STEARATES, 2018-2030 (USD MILLION)
  • TABLE 172. AUSTRALIA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PETROCHEMICALS, 2018-2030 (USD MILLION)
  • TABLE 173. AUSTRALIA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY GLYCOLS, 2018-2030 (USD MILLION)
  • TABLE 174. CHINA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 175. CHINA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 176. CHINA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 177. CHINA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CAPSULES, 2018-2030 (USD MILLION)
  • TABLE 178. CHINA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 179. CHINA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 180. CHINA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CELLULOSE, 2018-2030 (USD MILLION)
  • TABLE 181. CHINA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY STARCH, 2018-2030 (USD MILLION)
  • TABLE 182. CHINA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SUGARS, 2018-2030 (USD MILLION)
  • TABLE 183. CHINA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY OLEOCHEMICALS, 2018-2030 (USD MILLION)
  • TABLE 184. CHINA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY MINERAL STEARATES, 2018-2030 (USD MILLION)
  • TABLE 185. CHINA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PETROCHEMICALS, 2018-2030 (USD MILLION)
  • TABLE 186. CHINA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY GLYCOLS, 2018-2030 (USD MILLION)
  • TABLE 187. INDIA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 188. INDIA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 189. INDIA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 190. INDIA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CAPSULES, 2018-2030 (USD MILLION)
  • TABLE 191. INDIA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 192. INDIA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 193. INDIA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CELLULOSE, 2018-2030 (USD MILLION)
  • TABLE 194. INDIA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY STARCH, 2018-2030 (USD MILLION)
  • TABLE 195. INDIA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SUGARS, 2018-2030 (USD MILLION)
  • TABLE 196. INDIA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY OLEOCHEMICALS, 2018-2030 (USD MILLION)
  • TABLE 197. INDIA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY MINERAL STEARATES, 2018-2030 (USD MILLION)
  • TABLE 198. INDIA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PETROCHEMICALS, 2018-2030 (USD MILLION)
  • TABLE 199. INDIA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY GLYCOLS, 2018-2030 (USD MILLION)
  • TABLE 200. INDONESIA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 201. INDONESIA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 202. INDONESIA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 203. INDONESIA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CAPSULES, 2018-2030 (USD MILLION)
  • TABLE 204. INDONESIA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 205. INDONESIA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 206. INDONESIA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CELLULOSE, 2018-2030 (USD MILLION)
  • TABLE 207. INDONESIA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY STARCH, 2018-2030 (USD MILLION)
  • TABLE 208. INDONESIA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SUGARS, 2018-2030 (USD MILLION)
  • TABLE 209. INDONESIA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY OLEOCHEMICALS, 2018-2030 (USD MILLION)
  • TABLE 210. INDONESIA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY MINERAL STEARATES, 2018-2030 (USD MILLION)
  • TABLE 211. INDONESIA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PETROCHEMICALS, 2018-2030 (USD MILLION)
  • TABLE 212. INDONESIA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY GLYCOLS, 2018-2030 (USD MILLION)
  • TABLE 213. JAPAN ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 214. JAPAN ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 215. JAPAN ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 216. JAPAN ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CAPSULES, 2018-2030 (USD MILLION)
  • TABLE 217. JAPAN ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 218. JAPAN ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 219. JAPAN ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CELLULOSE, 2018-2030 (USD MILLION)
  • TABLE 220. JAPAN ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY STARCH, 2018-2030 (USD MILLION)
  • TABLE 221. JAPAN ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SUGARS, 2018-2030 (USD MILLION)
  • TABLE 222. JAPAN ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY OLEOCHEMICALS, 2018-2030 (USD MILLION)
  • TABLE 223. JAPAN ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY MINERAL STEARATES, 2018-2030 (USD MILLION)
  • TABLE 224. JAPAN ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PETROCHEMICALS, 2018-2030 (USD MILLION)
  • TABLE 225. JAPAN ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY GLYCOLS, 2018-2030 (USD MILLION)
  • TABLE 226. MALAYSIA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 227. MALAYSIA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 228. MALAYSIA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 229. MALAYSIA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CAPSULES, 2018-2030 (USD MILLION)
  • TABLE 230. MALAYSIA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 231. MALAYSIA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 232. MALAYSIA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CELLULOSE, 2018-2030 (USD MILLION)
  • TABLE 233. MALAYSIA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY STARCH, 2018-2030 (USD MILLION)
  • TABLE 234. MALAYSIA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SUGARS, 2018-2030 (USD MILLION)
  • TABLE 235. MALAYSIA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY OLEOCHEMICALS, 2018-2030 (USD MILLION)
  • TABLE 236. MALAYSIA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY MINERAL STEARATES, 2018-2030 (USD MILLION)
  • TABLE 237. MALAYSIA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PETROCHEMICALS, 2018-2030 (USD MILLION)
  • TABLE 238. MALAYSIA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY GLYCOLS, 2018-2030 (USD MILLION)
  • TABLE 239. PHILIPPINES ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 240. PHILIPPINES ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 241. PHILIPPINES ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 242. PHILIPPINES ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CAPSULES, 2018-2030 (USD MILLION)
  • TABLE 243. PHILIPPINES ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 244. PHILIPPINES ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 245. PHILIPPINES ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CELLULOSE, 2018-2030 (USD MILLION)
  • TABLE 246. PHILIPPINES ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY STARCH, 2018-2030 (USD MILLION)
  • TABLE 247. PHILIPPINES ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SUGARS, 2018-2030 (USD MILLION)
  • TABLE 248. PHILIPPINES ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY OLEOCHEMICALS, 2018-2030 (USD MILLION)
  • TABLE 249. PHILIPPINES ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY MINERAL STEARATES, 2018-2030 (USD MILLION)
  • TABLE 250. PHILIPPINES ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PETROCHEMICALS, 2018-2030 (USD MILLION)
  • TABLE 251. PHILIPPINES ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY GLYCOLS, 2018-2030 (USD MILLION)
  • TABLE 252. SINGAPORE ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 253. SINGAPORE ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 254. SINGAPORE ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 255. SINGAPORE ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CAPSULES, 2018-2030 (USD MILLION)
  • TABLE 256. SINGAPORE ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 257. SINGAPORE ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 258. SINGAPORE ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CELLULOSE, 2018-2030 (USD MILLION)
  • TABLE 259. SINGAPORE ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY STARCH, 2018-2030 (USD MILLION)
  • TABLE 260. SINGAPORE ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SUGARS, 2018-2030 (USD MILLION)
  • TABLE 261. SINGAPORE ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY OLEOCHEMICALS, 2018-2030 (USD MILLION)
  • TABLE 262. SINGAPORE ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY MINERAL STEARATES, 2018-2030 (USD MILLION)
  • TABLE 263. SINGAPORE ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PETROCHEMICALS, 2018-2030 (USD MILLION)
  • TABLE 264. SINGAPORE ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY GLYCOLS, 2018-2030 (USD MILLION)
  • TABLE 265. SOUTH KOREA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 266. SOUTH KOREA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 267. SOUTH KOREA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 268. SOUTH KOREA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CAPSULES, 2018-2030 (USD MILLION)
  • TABLE 269. SOUTH KOREA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 270. SOUTH KOREA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 271. SOUTH KOREA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CELLULOSE, 2018-2030 (USD MILLION)
  • TABLE 272. SOUTH KOREA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY STARCH, 2018-2030 (USD MILLION)
  • TABLE 273. SOUTH KOREA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SUGARS, 2018-2030 (USD MILLION)
  • TABLE 274. SOUTH KOREA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY OLEOCHEMICALS, 2018-2030 (USD MILLION)
  • TABLE 275. SOUTH KOREA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY MINERAL STEARATES, 2018-2030 (USD MILLION)
  • TABLE 276. SOUTH KOREA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PETROCHEMICALS, 2018-2030 (USD MILLION)
  • TABLE 277. SOUTH KOREA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY GLYCOLS, 2018-2030 (USD MILLION)
  • TABLE 278. TAIWAN ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 279. TAIWAN ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 280. TAIWAN ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 281. TAIWAN ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CAPSULES, 2018-2030 (USD MILLION)
  • TABLE 282. TAIWAN ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 283. TAIWAN ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 284. TAIWAN ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CELLULOSE, 2018-2030 (USD MILLION)
  • TABLE 285. TAIWAN ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY STARCH, 2018-2030 (USD MILLION)
  • TABLE 286. TAIWAN ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SUGARS, 2018-2030 (USD MILLION)
  • TABLE 287. TAIWAN ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY OLEOCHEMICALS, 2018-2030 (USD MILLION)
  • TABLE 288. TAIWAN ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY MINERAL STEARATES, 2018-2030 (USD MILLION)
  • TABLE 289. TAIWAN ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PETROCHEMICALS, 2018-2030 (USD MILLION)
  • TABLE 290. TAIWAN ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY GLYCOLS, 2018-2030 (USD MILLION)
  • TABLE 291. THAILAND ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 292. THAILAND ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 293. THAILAND ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 294. THAILAND ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CAPSULES, 2018-2030 (USD MILLION)
  • TABLE 295. THAILAND ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 296. THAILAND ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 297. THAILAND ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CELLULOSE, 2018-2030 (USD MILLION)
  • TABLE 298. THAILAND ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY STARCH, 2018-2030 (USD MILLION)
  • TABLE 299. THAILAND ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SUGARS, 2018-2030 (USD MILLION)
  • TABLE 300. THAILAND ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY OLEOCHEMICALS, 2018-2030 (USD MILLION)
  • TABLE 301. THAILAND ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY MINERAL STEARATES, 2018-2030 (USD MILLION)
  • TABLE 302. THAILAND ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PETROCHEMICALS, 2018-2030 (USD MILLION)
  • TABLE 303. THAILAND ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY GLYCOLS, 2018-2030 (USD MILLION)
  • TABLE 304. VIETNAM ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 305. VIETNAM ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 306. VIETNAM ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET S